samedan logo
 
 
spacer
home > pmps > winter 2017 > inhalation education
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Inhalation Education

There are several advantages when using inhaled therapeutics, and they offer promising future growth in the respiratory market. According to the NIH, a nominal dose is ‘the total prescribed dose’ of an inhalable therapeutic. Commonly observed actual amounts (medicament effectively reaching the lung), however, range between 6 and 60% of the nominal measurement. Such incomplete prescriptions pose safety risks to patients and reduce the effectiveness of their treatments. The successful use of respiratory delivery devices depends on a number of considerations, including:
  • Properties of the lung
  • Disease state
  • Breathing patterns
  • Delivery techniques


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Joining the company just a few years after its creation, Craig Baker is Vice President at Noble. He holds an undergraduate degree from the University of Iowa, US, and a Master’s degree from the University of South Carolina, US. In addition, Craig has 10 years of management experience in the marketing industry and the pharmaceutical and healthcare field. This unique insight into both industries is an important advantage for the future growth of Noble.
spacer
Craig Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Quinten Health Closes its Financing Round to Advance Disease Modelling Platforms and Virtual Twins in Real-World

Paris, September 21st, 2022 – Life Science Newswire – QUINTEN HEALTH, a pioneer in real-world data science, Artificial Intelligence (AI) and Machine Learning (ML) for precision care, today announces that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world, as part of the Quinten Group's €14 million growth equity investment from TECHLIFE CAPITAL and MACSF, essentially dedicated to the healthcare activities of the Quinten group.
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement